Telemus Capital, LLC Abiomed Inc Transaction History

Telemus Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$175.89 - $279.23 $351,780 - $558,460	-2,000 Closed	0 $0
Q1 2019 May 02, 2019	SELL	$276.39 - $362.25 $9,950 - $13,041	-36 Reduced 1.77%	2,000 $571,000
Q4 2018 Feb 06, 2019	SELL	$281.08 - $444.25 $12,648 - $19,991	-45 Reduced 2.16%	2,036 $662,000
Q1 2018 Apr 27, 2018	SELL	$192.49 - $295.85 $3,464 - $5,325	-18 Reduced 0.86%	2,081 $606,000
Q4 2017 Feb 02, 2018	BUY	$168.78 - $199.74 $16,709 - $19,774	99 Added 4.95%	2,099 $394,000
Q2 2017 Apr 03, 2018	SELL	N/A	-5,000 Reduced 71.43%	2,000 $287,000
Q1 2017 Apr 03, 2018	BUY	N/A	7,000	7,000 $876,000

137K

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

Get notified when there are updates to the investment portfolio of Telemus Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Telemus Capital, LLC with notifications on news.